ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Evaluation of late aortic insufficiency with continuous flow left ventricular assist device

Thursday, September 17, 2015

Submitted by

CTSNet Staff

Source

Source Name: Eur J Cardiothorac Surg

Source URL: http://ejcts.oxfordjournals.org/content/48/3/400.abstract

Author(s)

Arudo Hiraoka, Jeffrey E. Cohen, Yasuhiro Shudo, John W. MacArthur, Jr, Jessica L. Howard, Alexander S. Fairman, Pavan Atluri, James N. Kirkpatrick, and Y. Joseph Woo

The paper evaluates de novo development of aortic insufficiency (AI) following implantation of continuous flow left ventricular assist (84 HeartMate II, 13 HeartWare, 2 VentrAssist). Preoperatively, 17 patients had mild AI, which did not change later. Fourty-three of the other 82 patients developed new AI, with no influence on survival. Rate of freedom from de novo AI at 1 year after VAD implantation was 35.9%. Smaller body surface area, larger aortic root diameter and higher pulmonary artery systolic pressure were identified as the independent preoperative risk factors.